Search - tctmd.com

Displaying 301 - 320 of 1289

Sort: Relevancy | Date

Presentation NY Valves 2024

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

Presenter: Sean P. Pinney

June 07, 2024

Presentation NY Valves 2024

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Presenter: Yan Topilsky

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Presenter: Julio Cesar Echarte Morales

June 06, 2024

Presentation NY Valves 2024

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

Presenter: Toshiki Kuno

June 06, 2024

Presentation NY Valves 2024

Role of Exercise Testing in Assessment of AR

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Presenter: Aarti Patil

June 06, 2024

Presentation NY Valves 2024

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Presenter: Lukas Stolz

June 06, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Presenter: Jonathan Michel

June 06, 2024

Presentation NY Valves 2024

Compassionate Use Tendyne Transcatheter Mitral Valve Replacement in an ESRD Patient for Severe Calcified Mitral Stenosis and Regurgitation With Complete Resolution of Pulmonary Hypertension Allowing Listing for Renal Transplantation

Presenter: Sukhdeep Singh Basra

June 06, 2024

Presentation NY Valves 2024

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Presenter: Thomas E. Waggoner

June 06, 2024

Presentation NY Valves 2024

Closing the Gap: A Case of Definitive Reduction in Mitral Regurgitation Using Mitral Transcatheter Edge-to-Edge Reduction

Presenter: Matthew Summers

June 06, 2024

Presentation NY Valves 2024

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

Presenter: UTTAM SINGH

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

Advertisement

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

Role of Exercise Testing in Assessment of AR

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Compassionate Use Tendyne Transcatheter Mitral Valve Replacement in an ESRD Patient for Severe Calcified Mitral Stenosis and Regurgitation With Complete Resolution of Pulmonary Hypertension Allowing Listing for Renal Transplantation

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Closing the Gap: A Case of Definitive Reduction in Mitral Regurgitation Using Mitral Transcatheter Edge-to-Edge Reduction

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

JenaValve Following Previous Ross Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content